A medical-supplies company made a $43 million repurchase of its own shares last year, buoying the stock before bad news hit, even as four top managers were selling company shares.
- A medical-supplies firm repurchased a significant amount of its own shares, boosting the stock’s value, while four top executives sold their company shares. A month later, the stock experienced a 9% drop following the announcement of poor earnings.
- Some employees within the firm expressed concerns about the trading activities. The investor-relations chief, after raising questions about the company’s financial accuracy, declined to sign an internal form and was subsequently forced out.
Read the full story here.